Pasmol Pain Relieving
NDC Package 61361-820-03

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Pasmol Pain Relieving is adults and children three years of age and older: apply to affected area not more than 3-4 times daily.Children under 3 years of age: consult a doctor. Marketed by Grafor, Inc., this product is identified by NDC 61361-820 and is authorized under FDA application part348.

Identification & Billing

NDC Package Code
61361-820-03
Package Description
85 g in 1 JAR
Product Code
61361-820
11-Digit Billing Format
61361082003
RxNorm Crosswalk
  • RxCUI: 1608469 - menthol 5 % / methyl salicylate 14 % Topical Cream
  • RxCUI: 1608469 - menthol 50 MG/ML / methyl salicylate 140 MG/ML Topical Cream
  • RxCUI: 1608474 - PASMOL 5 % / 14 % Topical Cream
  • RxCUI: 1608474 - menthol 50 MG/ML / methyl salicylate 140 MG/ML Topical Cream [Pasmol]
  • RxCUI: 1608474 - Pasmol (menthol 5 % / methyl salicylate 14 % ) Topical Cream

Clinical Specifications

Proprietary Name
Pasmol Pain Relieving
Dosage Form
-
Usage Information
Adults and children three years of age and older: apply to affected area not more than 3-4 times daily.Children under 3 years of age: consult a doctor

Regulatory & Marketing

Labeler Name
Grafor, Inc.
FDA Application #
part348
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
04-08-2015
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 61361-820-03 identifies a specific commercial package of 85 g in 1 jar of Pasmol Pain Relieving, labeled by Grafor, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Grafor, Inc. on April 08, 2015. The current certification is valid through December 31, 2017.

How is this Grafor, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 61361082003. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
61361-820-03
11-Digit CMS (5-4-2)
61361-0820-03

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.